Published in J Bone Miner Res on October 01, 1991
Osteogenic response and osteoprotective effects in vivo of a nanostructured titanium surface with antibacterial properties. J Mater Sci Mater Med (2016) 0.75
Parathyroid hormonelike protein from human renal carcinoma cells. Structural and functional homology with parathyroid hormone. J Clin Invest (1987) 2.41
Evidence that increased circulating 1 alpha, 25-dihydroxyvitamin D is the probable cause for abnormal calcium metabolism in sarcoidosis. J Clin Invest (1979) 2.02
Computerized discharge summaries. Arch Phys Med Rehabil (1979) 1.60
Vitamin-D-dependent rickets type II. Resistance of target organs to 1,25-dihydroxyvitamin D. N Engl J Med (1978) 1.59
Staurosporine inhibits protein kinase C and prevents phorbol ester-mediated leukotriene D4 receptor desensitization in RBL-1 cells. Mol Pharmacol (1988) 1.35
In vivo-like drug responses of human tumors growing in three-dimensional gel-supported primary culture. Proc Natl Acad Sci U S A (1987) 1.31
Human transforming growth factor-alpha stimulates bone resorption in vitro. J Clin Invest (1985) 1.28
Cadmium accelerates bone loss in ovariectomized mice and fetal rat limb bones in culture. Proc Natl Acad Sci U S A (1988) 1.22
Evidence for extrarenal production of 1 alpha ,25-dihydroxyvitamin D in man. J Clin Invest (1982) 1.21
Inhibition by steroids of parathyroid hormone-induced Ca45 release from embryonic rat bone in vitro. J Pharmacol Exp Ther (1969) 1.19
Leukotriene D4 treatment of bovine aortic endothelial cells and murine smooth muscle cells in culture results in an increase in phospholipase A2 activity. J Biol Chem (1986) 1.17
Hypercalcemia and increases in serum hormone value during prolonged administration of 1alpha,25-dihydroxyvitamin D. N Engl J Med (1978) 1.16
G alpha12/G alpha13 subunits of heterotrimeric G proteins mediate parathyroid hormone activation of phospholipase D in UMR-106 osteoblastic cells. Endocrinology (2005) 1.12
Purification of a phospholipase A2 from human monocytic leukemic U937 cells. Calcium-dependent activation and membrane association. J Biol Chem (1990) 1.11
Altered methionine metabolism occurs in all members of a set of diverse human tumor cell lines. J Cell Physiol (1984) 1.08
Abnormal regulation of circulating 25-hydroxyvitamin D in the Williams syndrome. N Engl J Med (1982) 1.08
Effects of glucagon on serum calcium in the rat and on bone resorption in tissue culture. Endocrinology (1970) 1.04
The metabolic defect of methionine dependence occurs frequently in human tumor cell lines. Biochem Biophys Res Commun (1983) 1.02
Evidence for abnormal regulation of circulating 1 alpha, 25-dihydroxyvitamin D in patients with pulmonary tuberculosis and normal calcium metabolism. Calcif Tissue Int (1984) 1.01
Comparison of fetal rat limb bones and neonatal mouse calvaria: effects of parathyroid hormone and 1,25-dihydroxyvitamin D3. Calcif Tissue Int (1983) 1.01
Effect of leukotrienes, bradykinin and calcium ionophore (A 23187) on bovine endothelial cells: release of prostacyclin. Prostaglandins (1986) 1.00
Leukotriene-induced hydrolysis of inositol lipids in guinea pig lung: mechanism of signal transduction for leukotriene-D4 receptors. Mol Pharmacol (1987) 0.99
Peptidoleukotrienes: distinct receptors for leukotriene C4 and D4 in the guinea-pig lung. Biochem Biophys Res Commun (1983) 0.98
Bleomycin and talisomycin sequence-specific strand scission of DNA: a mechanism of double-strand cleavage. Cancer Res (1982) 0.96
Evidence for abnormal regulation of circulating 1 alpha,25-dihydroxyvitamin D in patients with sarcoidosis and normal calcium metabolism. J Clin Invest (1980) 0.96
Hypercalcemia during long-term treatment with 1,25-dihydroxyvitamin D3 in hypoparathyroidism. N Engl J Med (1979) 0.96
Discovery of TBC11251, a potent, long acting, orally active endothelin receptor-A selective antagonist. J Med Chem (1997) 0.95
Intermolecular cross-linking of DNA through bifunctional intercalation of an antitumor antibiotic, luzopeptin A (BBM-928A). Cancer Res (1983) 0.94
A bioassay capable of measuring 1 picogram of 1,25-dihydroxyvitamin D3. J Clin Endocrinol Metab (1978) 0.93
Elevated overall rates of transmethylation in cell lines from diverse human tumors. In Vitro (1984) 0.92
SKF 104353, a high affinity antagonist for human and guinea pig lung leukotriene D4 receptor, blocked phosphatidylinositol metabolism and thromboxane synthesis induced by leukotriene D4. Mol Pharmacol (1987) 0.91
Enhanced in vitro selective toxicity of chemotherapeutic agents for human cancer cells based on a metabolic defect. J Natl Cancer Inst (1986) 0.91
Interactions of a new antitumor antibiotic BBM-928A with deoxyribonucleic acid. Bifunctional intercalative binding studied by fluorometry and viscometry. Biochemistry (1980) 0.91
Identification and characterization of leukotriene D4 receptors and signal transduction processes in rat basophilic leukemia cells. J Biol Chem (1987) 0.91
DNA supercoiling, shortening, and induction of single-strand regions by cis-diamminedichloroplatinum(II). Cancer Res (1981) 0.90
Bioassay of 1,25-dihydroxyvitamin D in human plasma purified by partition, alkaline extraction, and high-pressure chromatography. Anal Biochem (1980) 0.90
Parathyroid hormone and calcitonin modify inositol phospholipid metabolism in fetal rat limb bones. J Bone Miner Res (1986) 0.90
Leukotriene D4 receptor-mediated synthesis and release of arachidonic acid metabolites in guinea pig lung: induction of thromboxane and prostacyclin biosynthesis by leukotriene D4. J Pharmacol Exp Ther (1986) 0.88
Insulin-like growth factor I production is essential for anabolic effects of thyroid hormone in osteoblasts. J Bone Miner Res (2000) 0.88
Parathyroid hormone-induced resorption in fetal rat limb bones is associated with production of the metalloproteinases collagenase and gelatinase B. J Bone Miner Res (1996) 0.88
Factors influencing stroke rehabilitation. Stroke (1971) 0.88
Reduced availability of endogenously synthesized methionine for S-adenosylmethionine formation in methionine-dependent cancer cells. Proc Natl Acad Sci U S A (1982) 0.88
The binding of leukotriene C4 and leukotriene D4 to membranes of a smooth muscle cell line (BC3H1) and evidence that leukotriene induced contraction in these cells is mediated by thromboxane, protein and RNA syntheses. Eur J Pharmacol (1985) 0.87
Identification of specific binding sites for leukotriene C4 in human fetal lung. Prostaglandins (1984) 0.87
Enzymatic isolation of cells from neonatal calvaria using two purified enzymes from Clostridium histolyticum. Exp Cell Res (1983) 0.87
Serum interleukin-6 and bone metabolism in patients with thyroid function disorders. J Clin Endocrinol Metab (1997) 0.87
Differential inhibition of histamine release from mast cells by protein kinase C inhibitors: staurosporine and K-252a. Biochem Pharmacol (1990) 0.86
1 alpha,25-dihydroxyvitamin D3 corrects osteomalacia in hypoparathyroidism and pseudohypoparathyroidism. Acta Endocrinol (Copenh) (1983) 0.86
Inhibition of phosphoinositide-specific phospholipase C by manoalide. Mol Pharmacol (1987) 0.86
Regulation of ligand binding to leukotriene D4 receptors: effects of cations and guanine nucleotides. Eur J Pharmacol (1984) 0.86
Isolation of osteoclasts from fetal rat long bones. Calcif Tissue Int (1982) 0.85
High-affinity leukotriene receptor antagonists. Synthesis and pharmacological characterization of 2-hydroxy-3-[(2-carboxyethyl)thio]-3-[2-(8-phenyloctyl)phenyl] propanoic acid. J Med Chem (1987) 0.85
Calcium transport in isolated bone cells. III. Effects of parathyroid hormone and cyclic 3',5'-AMP. Endocrinology (1975) 0.85
New leukotriene B4 receptor antagonist: leucettamine A and related imidazole alkaloids from the marine sponge Leucetta microraphis. J Nat Prod (1993) 0.85
Endothelin-1 actions on resorption, collagen and noncollagen protein synthesis, and phosphatidylinositol turnover in bone organ cultures. Endocrinology (1992) 0.84
Compactin suppresses bone resorption by inhibiting the fusion of prefusion osteoclasts and disrupting the actin ring in osteoclasts. J Bone Miner Res (2000) 0.84
Cytotoxic activity, tumor accumulation, and tissue distribution of ruthenium-103-labeled bleomycin. J Natl Cancer Inst (1981) 0.84
Bone resorbing activity of vitamin D metabolites and congeners in vitro: influence of hydroxyl substituents in the A ring. Endocrinology (1975) 0.84
Binding of leukotriene B4 and its analogs to human polymorphonuclear leukocyte membrane receptors. Prostaglandins (1987) 0.84
Potassium effects on bone: comparison of two model systems. Am J Physiol (1983) 0.84
Identification and characterization of leukotriene D4 receptors in adult and fetal human lung. Biochem Pharmacol (1985) 0.84
Leukotriene B4 induces formation of inositol phosphates in rat peritoneal polymorphonuclear leukocytes. Mol Pharmacol (1986) 0.84
The D vitamins and bone. Pharmacol Rev (1980) 0.84
U-73122, a phospholipase C antagonist, inhibits effects of endothelin-1 and parathyroid hormone on signal transduction in UMR-106 osteoblastic cells. Biochim Biophys Acta (1994) 0.84
Bone anabolic responses to mechanical load in vitro involve COX-2 and constitutive NOS. Connect Tissue Res (2004) 0.84
Leukotriene C4 ([3H]-LTC4) binding to membranes isolated from a hamster smooth muscle cell line (DDT1MF2). Life Sci (1984) 0.83
Comparison of bleomycin A2 and talisomycin A specific fragmentation of linear duplex DNA. Biochem Biophys Res Commun (1979) 0.83
Fluoride substitution of vitamin D analogs at C-26 and C-27: enhancement of activity of 25-hydroxyvitamin D but not of 1,25-dihydroxyvitamin D on bone and intestine in vitro. J Pharmacol Exp Ther (1984) 0.83
Studies on the mechanism of desensitization of the parathyroid hormone-stimulated calcium signal in UMR-106 cells: reversal of desensitization by alkaline phosphatase but not by protein kinase C downregulation. J Bone Miner Res (1994) 0.82
Differential effects of manoalide on secreted and intracellular phospholipases. Biochem Pharmacol (1987) 0.82
Diurnal rhythms in Ca transfer into bone, Ca release from bone, and bone resorbing activity in serum of rats. Am J Physiol (1992) 0.82
Effects of facilitation exercise techniques in stroke rehabilitation. Arch Phys Med Rehabil (1970) 0.82
A monolog on analogs: in vitro effects of vitamin D metabolites and consideration of the mineralization question. Calcif Tissue Int (1981) 0.82
Leukotriene D4-induced activation of protein kinase C in rat basophilic leukemia cells. Eur J Pharmacol (1988) 0.82
MicroCT quantification of in vitro bone resorption of neonatal murine calvaria exposed to IL-1 or PTH. J Struct Biol (2004) 0.81
Demonstration that circulating 1 alpha, 25-dihydroxyvitamin D is loosely regulated in normal children. J Clin Invest (1981) 0.81
10-Keto or 25-hydroxy substitution confer equivalent in vitro bone-resorbing activity to vitamin D3. Arch Biochem Biophys (1985) 0.81
Levodopa therapy effects on natural history of Parkinsonism. Arch Neurol (1972) 0.81
Phosphatidylcholine-specific phospholipase C inhibitor, tricyclodecan-9-yl xanthogenate (D609), increases phospholipase D-mediated phosphatidylcholine hydrolysis in UMR-106 osteoblastic osteosarcoma cells. Biochim Biophys Acta (2000) 0.81
Interaction of cis-diamminedichloroplatinum(II) with PM-2 DNA. Cancer Res (1980) 0.81
Transient activation of topoisomerase I in leukotriene D4 signal transduction in human cells. Biochem J (1990) 0.81
Molecular heterogeneity of leukotriene receptors: correlation of smooth muscle contraction and radioligand binding in guinea-pig lung. J Pharmacol Exp Ther (1985) 0.80
Vertebral bone resorption in vitro: effects of parathyroid hormone, calcitonin, 1,25 dihydroxyvitamin D3, epidermal growth factor, prostaglandin E2, and estrogen. Calcif Tissue Int (1987) 0.80
Platelet-activating factor-induced phosphoinositide metabolism in differentiated U-937 cells in culture. J Pharmacol Exp Ther (1989) 0.80
Interaction of covalently closed circular PM-2 DNA and hedamycin. Biochem Biophys Res Commun (1979) 0.80
Mechanisms of regulation of receptors and signal transduction pathways for the peptidyl leukotrienes. Ann N Y Acad Sci (1988) 0.79
Effects of second-generation platinum analogs on isolated PM-2 DNA and their cytotoxicity in vitro and in vivo. Cancer Res (1980) 0.79
Bone resorbing activities of 24-hydroxy stereoisomers of 24-hydroxyvitamin D3 and 24,25-dihydroxyvitamin D3. Biochem Biophys Res Commun (1975) 0.79
Reduced free-methionine in methionine-dependent SV40-transformed human fibroblasts synthesizing apparently normal amounts of methionine. J Cell Physiol (1983) 0.79
The preparation of [35S]homocysteine thiolactone free of [35S]methionine. J Biochem Biophys Methods (1982) 0.79
Leukotriene B4-induced homologous desensitization of calcium mobilization and phosphoinositide metabolism in U-937 cells. J Pharmacol Exp Ther (1988) 0.79
Interaction between amrinone and parathyroid hormone on bone in culture. Am J Physiol (1982) 0.79
Cyclosporine A and FK506 induce osteoclast apoptosis in mouse bone marrow cell cultures. Bone (2004) 0.79
Identification and characterization of the substance P receptor in sheep intestinal smooth muscle membranes. J Pharmacol Exp Ther (1990) 0.79
Leukotriene D4 binding and signal transduction in rat glomerular mesangial cells. Am J Physiol (1989) 0.79
Solubilization of [3H]leukotriene D4 receptor complex from guinea pig lung membranes. Mol Pharmacol (1986) 0.79
Bone-resorbing activity of analogues of 25-hydroxycholecalciferol and 1,25-dihydroxycholecalciferol: effects of side chain modification and stereoisomerization on responses of fetal rat bones in vitro. Mol Pharmacol (1976) 0.79
Insulin and thyroid hormones stimulate matrix metabolism in primary cultures of articular chondrocytes from young rabbits independently and in combination. Connect Tissue Res (1994) 0.79
Levodopa and physical therapy in treatment of patients with Parkinson's disease. Arch Phys Med Rehabil (1970) 0.78